FDA authorizes another OTC COVID-19 test

Nov 08, 2021 - 02:29 PM
FDA product update

The Food and Drug Administration Friday authorized another over-the-counter COVID-19 diagnostic test for emergency use. The iHealth COVID-19 Antigen Rapid Test delivers results in 15 minutes. The company anticipates producing 100 million tests per month, with capacity increasing to 200 million per month in early 2022, FDA said.

Related News Articles

Headline
FDA approves COVID-19 antigen test, first chikungunya vaccine
The Food and Drug Administration Nov. 9 cleared for marketing the Flowflex COVID-19 Antigen Home Test, the first COVID-19 antigen test and second COVID-19 at-…
Headline
HHS awards $600M to make COVID-19 tests; public can order 4 more free
The Department of Health and Human Services’ Administration for Strategic Preparedness and Response yesterday awarded $600 million for 12 domestic COVID-19…
Headline
NIOSH revokes respirators temporarily approved for COVID-19 PHE
The National Institute for Occupational Safety and Health this week revoked eight N95 filtering facepiece respirator approvals and four powered air-…
Headline
FDA updates use recommendations for Halyard surgical N95 respirator 
In response to questions from AHA and others and informed by testing results, the Food and Drug Administration April 21 announced that health care…
Headline
FDA: Don’t use certain N95 respirators and masks made by O&M Halyard
Health care providers and consumers should not use certain N95 respirators made by O&M Halyard because they do not meet quality and performance…
Headline
HHS: FDA COVID-19 emergency use authorizations remain in effect
Health and Human Services Secretary Xavier Becerra this week amended the February 2020 COVID-19 emergency use authorization declaration so that the Food…